Hutchison China MediTech Ltd ADR diskutieren
Hutchison China MediTech Ltd ADR
WKN: A2AF74 / Symbol: HCM / Name: Chi-Med / Aktie / Pharmazeutika / Mid Cap /
20,20 €
5,70 %
HUTCHMED (China) Limited (NASDAQ: HCM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited (NASDAQ: HCM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $50.00 price target on the stock.
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited (NASDAQ: HCM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $50.00 price target on the stock.
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited (NASDAQ: HCM) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $22.10 price target on the stock.
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited (NASDAQ: HCM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited (NASDAQ: HCM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for HCM provided by MarketBeat
Neueste Beiträge
StockNews_com in Western Gas Partners L.P. diskutieren